NANT CANCER VACCINE Trademark

Trademark Overview

On Friday, February 17, 2023, a trademark application was filed for NANT CANCER VACCINE with the United States Patent and Trademark Office. The USPTO has given the NANT CANCER VACCINE trademark a serial number of 97800703. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, October 15, 2024. This trademark is owned by Nant Holdings IP, LLC. The NANT CANCER VACCINE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

medical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immuneoncology, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines biologics, cells and cell-derived preparations; providing medical and health information relating to pharmaceuticals, oncology, cancer, immuneoncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines, biologics, cells, and cell-derived preparations
nant cancer vaccine

General Information

Serial Number97800703
Word MarkNANT CANCER VACCINE
Filing DateFriday, February 17, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements

Goods and Servicesmedical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immuneoncology, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines biologics, cells and cell-derived preparations; providing medical and health information relating to pharmaceuticals, oncology, cancer, immuneoncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines, biologics, cells, and cell-derived preparations
NOT AVAILABLE"CANCER VACCINE"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 8, 2023
Primary Code044
First Use Anywhere DateTuesday, July 19, 2022
First Use In Commerce DateTuesday, July 19, 2022

Trademark Owner History

Party NameNant Holdings IP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 90232
Party NameNant Holdings IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 90232

Trademark Events

Event DateEvent Description
Tuesday, February 21, 2023NEW APPLICATION ENTERED
Wednesday, March 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 29, 2023ASSIGNED TO EXAMINER
Thursday, June 29, 2023NON-FINAL ACTION WRITTEN
Thursday, June 29, 2023NON-FINAL ACTION E-MAILED
Thursday, June 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 29, 2023NON-FINAL ACTION WRITTEN
Thursday, June 29, 2023NON-FINAL ACTION E-MAILED
Thursday, June 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 29, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, June 29, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, June 29, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 29, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, June 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 1, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 1, 2024SOU EXTENSION 1 FILED
Monday, April 1, 2024SOU EXTENSION 1 GRANTED
Monday, April 1, 2024TEAS STATEMENT OF USE RECEIVED
Monday, April 1, 2024USE AMENDMENT FILED
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 19, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, April 22, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, April 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 22, 2024NON-FINAL ACTION E-MAILED
Friday, October 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 15, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 15, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 22, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, July 22, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords

vaccine cancer nant diseases medical information providing vaccines human biologics animal cell preparations